glp-1 kidney disease Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis Potential kidney-protective and other effects
Description
Quick Answer: GLP-1 receptor agonists do not directly treat or improve Hashimoto's disease or its underlying autoimmune process, though they may be safely used for appropriate metabolic indications like type 2 diabetes or obesity in patients with this thyroid condition
2011;162(4):620-626.e1
Share your experiences, tips, and questions in the comments below
This content is not a substitute for professional medical advice or diagnosis
What is your budget
They were both first approved to treat type 2 diabetes, and clinical trials also showed that they induced a significant amount of weight loss
